Targacept, Inc. is a biopharmaceutical company engaged in the design, discovery and development of neuronal nicotinic receptors (NNR) Therapeutics for the treatment of multiple diseases and disorders of the central nervous system. The Company has clinical-stage product candidates for... more

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company’s principal biologic drug candidate, Prochymal, is being evaluated in... more

ViaCell, Inc., a wholly owned subsidiary of PerkinElmer, is dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible... more

MaxCyte was founded in 1999 to commercialize flow electroporation technology exclusively from the CBR Institute for Biomedical Research. The technology was intended for clinical use, and the application that had been proposed when the technology was first acquired involved loading 1 liter... more

Seattle Genetics, Inc. is a clinical-stage biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The Company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize the product candidate... more

StemCells, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of cell-based therapeutics to treat damage to, or degeneration of, major organ systems. The Company has product development programs for two cell types: the human neural stem cell and... more

SGX Pharmaceuticals (formerly Structural GenomiX) is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. SGX's oncology pipeline includes drug candidates from its enabling, proprietary FASTÔ drug discovery platform, such... more

Caprion offers its employees a dynamic and stimulating work environment, encouraging continuous innovation and the sharing of knowledge and ideas. We offer a comprehensive compensation package, including a competitive salary, participation in an employee stock option plan, a group... more

Tengion, a clinical stage biotechnology company, has pioneered the Autologous Organ Regeneration PlatformÔ that catalyzes the body's innate ability to regenerate. Tengion's neo-organs and neo-tissues in development, such as bladders and vessels, combine biocompatible materials and a... more

Aegera is committed to conducting rigorous clinical trials that demonstrate the safety and efficacy of our product candidates. We design our trials to provide us with the most robust and relevant data to understand how our products can have the most meaningful impact in the most... more

Lux Biosciences is a clinical stage biotechnology company specialized in the field of ophthalmic diseases. We are developing novel medications to treat the underlying causes of ophthalmic diseases and alleviate their symptoms, and if approved by regulatory authorities, we plan to... more

OncoGenex is a private biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. The company's three product candidates are designed to inhibit the production of specific proteins associated... more

Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the... more

DiaMedica Inc. (DiaMedica) is a biotechnology company developing treatments for type 2 diabetes based on a newly corroborated mechanism. The Company’s lead product, DM-71, is a synergistic combination of bethanechol and N-acetyl cysteine, drugs used to treat other unrelated human... more

Arteriocyte, a clinical stage biotechnology company located in Cleveland, Ohio and Hopkinton, Massachusetts, is developing proprietary, cellular-based therapeutics. The Company spun out of Case Western Reserve University in 2004 and is based upon research utilizing stem cells to stimulate... more

Ester Neurosciences is developing a unique, disease-modifying approach to combat neurological disorders that result from disrupted acetlycholinesterase (AChE) neuromodulation. "Cholinergic mechanisms represent a basic pathophysiological pathway underlying neurodeterioration that is... more

Stem Cell Therapeutics Corp. (SCT) is a Canada-based biotechnology company-focused on the development and commercialization of drug-based therapies to treat central nervous system diseases. SCT is engaged in the development of therapies that utilize drugs to stimulate a patient's own... more

Bayhill Therapeutics Inc. is focused on the translation of research into therapeutics by developing novel drugs for the treatment of autoimmune diseases. The company has established a product platform of antigen-specific therapeutics, BHT-DNA, with broad potential applications in treating... more

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class... more

Founded in April 2006, CoNCERT Pharmaceuticals is the first company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. CoNCERT applies its innovative precision deuterium chemistry platform to modify specific... more

Acucela Inc. is a clinical stage biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glaucoma, significantly affect quality of life for over 50 million people... more

Androclus is developing epitope-specific immunotherapy as a breakthrough technology for the treatment of autoimmune diseases. The proprietary technology platform is based on identification of compounds with specific immunomodulatory activity. In contrast to prior attempts at... more

Twinstrand specializes in the development of recombinant therapeutics for the treatment of human diseases. Using molecular genetic and combinatorial methods, the company is advancing a family of potent prodrugs that are activated by disease-associated proteases. Twinstrand's molecules... more

Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.

Molecular Therapeutics, Inc. (MRx) is a privately held biotechnology holding company that focuses on in-licensing promising pharmaceutical and medical device technologies in the late preclinical development phase and conducts proof-of-principle clinical (phase II) studies on a virtual... more

Tobira Therapeutics acquires, develops and commercializes innovative products for the treatment of important and unmet medical needs in infectious diseases such as HIV/AIDS, hepatitis, and other associated infectious conditions. At Tobira, we are committed to creating value for patients,... more

Spirogen is a clinical stage biotechnology company specialising in the development of targeted therapies for major diseases. The company was founded in 2000, has 28 employees and is venture capital funded. Spirogen's lead oncology drug candidate, SG 2000, is currently being evaluated in... more

Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing novel oncology compounds directed to cancer stem cell targets.

Pulmatrix was founded in 2003 by scientists from Harvard University and the Massachusetts Institute of Technology in order to tackle the problem of treating and preventing the spread of airborne and respiratory infectious disease. Pulmatrix is located in Lexington, Massachusetts.

Nuon Therapeutics, Inc. is a clinical stage biotechnology company that develops innovative small molecule drugs that address critical, unmet needs in autoimmune disease and pain. Nuon Therapeutics' initial programs, based on an exclusive license to technology developed by Imperial College... more

NeuroGeneration is a clinical stage biotechnology company with neural stem cell products targeting neurological disorders caused by cell loss or injury. Our mission is to lead the field of neural stem cell therapy for neurological disorders and become the top provider of autologous neural... more

OxThera is a clinical stage biotechnology company with its first product in phase III. The company is based in Sweden (Uppsala) and Florida (Gainesville). The company develops products, based on its cell- and enzyme based proprietary technologies, for metabolic disorders based on excess... more